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Abstract 
Glutamate is thought to be the excitatory neurotransmitter in the lateral geniculate nucleus (LGN) of the cat, 
mediating visual transmission from the retina via ionotropic receptors of both d,l-α-amino-3-hydroxy-5-α-methyl-4-
isoxazolepropionate and N-methyl-d-aspartate subtypes. Moreover, glutamate also exerts an important modulatory 
influence on LGN cells, where metabotropic glutamate receptors (mGluRs) seem to play a crucial role. Here we show 
in anesthetized adult cats that iontophoretic application of the specific mGluR5 antagonist 2-methyl-6-
(phenylethynyl)-pyridine (MPEP) produced two, distinctly different, effects on LGN neurons. Visual responses to 
flashing spots and drifting gratings were attenuated (decreased by an average of 59%) in 13 of 23 of the cells but 
augmented (increased by an average of 60%) in 10 of 23 of the cells. Further, in each case when the specific mGluR5 
agonist (R,S)-2-chloro-5-hydroxyphenylglycine was applied, the effects obtained were the opposite to those of 
MPEP. Data obtained in a second group of experiments to determine a possible interaction between mGluR5 
blockade by MPEP and glutamate ionotropic receptors show that, in the majority of neurons (11 of 15, 73%), the 
MPEP-mediated effects seem to be independent of N-methyl-d-aspartate and d,l-α-amino-3-hydroxy-5-α-methyl-4-
isoxazolepropionate receptor activity. Our results demonstrate a physiological role for mGluR5 in controlling retinal 
input and show, in vivo, a more intricate scenario than previously suggested, highlighting the complexity of 
metabotropic receptor interactions with excitatory and inhibitory elements in the thalamus. 
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Introduction 
Metabotropic glutamate receptors (mGluRs) have various modulatory functions in the central nervous 
system (Pin & Duvoisin, 1995; Conn & Pin, 1997; Anwyl, 1999). There are eight mGluR subtypes that 
are further segregated into three groups based on their sequence homology, pharmacology and coupling to 
second messenger systems (Pin & Duvoisin, 1995; Conn & Pin, 1997). The group I mGluRs (mGluR1 
and R5) couple to phospholipase C and inositol-1,4,5 trisphosphate turnover, while group II (mGluR2 and 
R3) and group III (mGluR4, R6, R7 and R8) negatively couple to cAMP turnover (Pin & Duvoisin, 1995; 
Conn & Pin, 1997). The role of mGluRs in synaptic transmission and plasticity depends on their coupling 
activity and their pre- and postsynaptic localization (Martin et al., 1992; Petralia et al., 1996; Shigemoto 
et al., 1996, 1997; Li et al., 1997). Group II and III mGluRs are presynaptic autoreceptors controlling 
glutamate release (Glaum & Miller, 1993; Burke & Hablitz, 1994; Gereau & Conn, 1995; Lovinger & 
McCool, 1995; Sanchez-Prieto et al., 1996; Schrader & Tasker, 1997; Anwyl, 1999; Bradley et al., 2000; 
Dube & Marshall, 2000), while group I mGluRs play a role in regulating neuronal excitability and in 
facilitating LTP and LTD at both pre- and postsynaptic levels (Herrero et al., 1992; Sanchez-Prieto et al., 
1996; Anwyl, 1999; Bortolotto et al., 1999; Manahan-Vaughan et al., 1999.; Schwartz & Alford, 2000; 
Chuang et al., 2001; Lee AC et al., 2002; Lee O et al., 2002; Gubellini et al., 2003) and also in 
potentiating N-methyl-d-aspartate (NMDA) (Doherty et al., 1997; Alagarsamy et al., 1999; Salt & Binns, 
2000; Pisani et al., 2001; Benquet et al., 2002) and d,l-α-amino-3-hydroxy-5-α-methyl-4-
isoxazolepropionate (AMPA) receptor-mediated responses (Ugolini et al., 1999). 
Recent work from our group on lateral geniculate nucleus (LGN) physiology has focused on the 
modulatory influence of the group I receptors, demonstrating that a fundamental component of this 
influence comes from the cortex and is mediated by mGluR1 (Rivadulla et al., 2002). Here, we aimed to 
explore the functional role of mGluR5. Interestingly, it has been shown that mGluR5 are spatially 
segregated from mGluR1 and are primarily located postsynaptically to retinal inputs in dendritic terminals 
of GABAergic interneurons (Godwin et al., 1996). This suggests a different role for mGluR5 within the 
cat's LGN, related to the incoming signal from the retina. It has been shown, in a series of elegant studies 
in vitro, that activation of mGluR receptors (presumably mGluR5) activate dendritic terminals inhibiting 
the postsynaptic LGN relay cell (Cox et al., 1998; Cox & Sherman, 2000). Therefore, we felt it logical to 
use an in vivo preparation to study the functional roles of mGluR5 in visually elicited responses and how 
LGN cells are affected by pharmacological manipulation of these receptors. We have taken advantage of 
the mGluR5 agonist (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) and antagonist 2-methyl-6-
(phenylethynyl)-pyridine (MPEP) (Doherty et al., 1997; Gasparini et al., 1999; Salt et al., 1999; Spooren 
et al., 2001). 
The data obtained revealed a more complex situation, on one hand confirming the putative role of 
mGluR5 in inhibitory control, inhibiting some relay cells, while, on the other hand, mGluR5 activation 
seemed able to up-regulate the visual excitability of other LGN relay cells, possibly by a mechanism 
involving NMDA and AMPA receptors. 
Materials and methods 
Animal preparation 
Experiments were performed on adult cats of either sex. Animals were anesthetized with halothane in 
nitrous oxide (70%) and oxygen (30%) (halothane, 5% for induction, 1.5–2% for surgery and 0.1–0.5% 
for maintenance). To prevent eye movements, animals were paralyzed with gallamine triethiodide 
(loading dose, 40 mg, maintenance, 10 mg/kg/h i.v. infusion). The end-tidal CO2 levels, 
electrocardiogram waveform, intersystolic interval and frequency of spindles in the electroencephalogram 
were monitored continuously throughout the experiment. The rate and depth of artificial respiration were 
adjusted to maintain end-tidal CO2 at 3.8–4.2%; the level of halothane was chosen to achieve a state of 
light anesthesia. Once a stable state was reached, any variation in the monitored parameters 
commensurate with a change in the depth of anesthesia was compensated for by alterations in the level of 
halothane. Wound margins were treated with lidocaine hydrochloride with epinephrine administered 
subcutaneously. Ear bars were coated with lidocaine gel. The eyes were treated with atropine 
methonitrate and phenylephrine hydrochloride, protected with zero power contact lenses and brought to 
focus on a semiopaque tangent screen 57 cm distant. Visual stimuli were viewed monocularly through 3-
mm artificial pupils. To further reduce possible eye movement artifacts, posts were fixed to the sclera. 
The procedures conformed to the guidelines of the Spanish Physiology Society, International Council for 
Laboratory Animal Science and European Union (statute no. 86/809). 
Recording and iontophoretic application of drugs 
Seven-barrelled micropipettes were used for iontophoretic ejection of drugs and single unit 
extracellular recording in the A laminae of the cat dorsal LGN. Drug barrels contained a selection of the 
following solutions: NaCl (3 m for recording), NMDA (0.1 m, pH 8.0), AMPA (10 mm in 75 mm NaCl, 
pH 8.5), ACh (1 m, pH 5), MPEP (10 mm in 150 mm NaCl, pH 5) CHPG (100 mm, pH 8) or pontamine 
sky blue (2% w/v in 0.5 m sodium acetate solution for histological reconstruction). ACh was included in 
the pipette for identifying relay cells on the basis of its excitatory effect (McCormick & Prince, 1987). 
Pipette tips were broken back to diameters ranging from 5 to 10 µm and each drug barrel was subject to a 
retention current of 5–25 nA of appropriate polarity. Ejecting DC currents were in the range of 30–
100 nA. A barrel with 1 m NaCl was used for current balancing. 
Visual stimulation and experimental design 
Cells were carefully classified by a battery of tests into X and Y groups of ON and OFF subtypes. 
Particular emphasis was placed on the linearity of spatial summation in the responses to sinusoidal 
gratings of the appropriate spatial frequency. Sinusoidally phase-reversed gratings were presented at a 
number of spatial phase positions in a randomized interleaved sequence, using the highest spatial 
frequency giving reliable responses. Fourier analysis produced first and second harmonic components of 
these responses, which were plotted against spatial phase. X cell responses were characterized by a 
strongly phase-dependent first harmonic which exhibited a clear null point while Y cell responses 
included a second harmonic component which was not strongly phase dependent. Other tests included the 
duration of the response to standing contrast over the receptive field center, the presence or absence of a 
shift effect, the strength of surround antagonism and size of receptive field center for a given eccentricity 
(Enroth-Cugell & Robson, 1966; Cleland et al., 1971; Derrington & Fuchs, 1979). Waveforms and time 
stamps were stored (Plexon Inc., USA) and we performed offline spike sorting in order to assess the 
isolation of the selected spike and recording stability. Computer-controlled visual stimuli (Lohmann 
Research Equipment, Germany) were presented monocularly on a monitor with a mean luminance of 
14 cd/m2 at a contrast of 0.6, refresh rate 128 Hz. Visual stimuli consisted of sinusoidal drifting wave 
gratings and spots of different size flashing on the receptive field. The spatiotemporal properties of the 
stimuli were optimally set for each cell. Receptive fields were mapped by forward correlation with sparse 
noise (Rivadulla et al., 2003). The stimulus space was divided into a 20 × 20 grid (grid spacing ranged 
from 8 to 20°). In a given stimulus run, a series of black or white squares were flashed singly for a brief 
period of time (30 ms) at each location on the grid in pseudo-random order. The multihistogram technique 
was used for quantitative assessment of receptive field parameters. Our basic experimental paradigm 
involved establishing control responses to a range of visual stimuli. Responses were collected for the 
entire duration of the stimulus and were averaged over 10–15 presentations. For drifting gratings, each 
presentation included 10 cycles of the stimulus. This was then repeated during continuous iontophoretic 
application of the drug of interest. Throughout the study, action potentials were timed and counted using 
the Plexon system. Data were analysed by plotting peristimulus time histograms from these recordings. 
Spikes obtained in both conditions (control/drug ejection) were compared after background activity was 
subtracted. Background activity was obtained from the presentation of blank stimulus (screen with mean 
luminance) intermixed with visual stimuli. 
In another set of experiments aimed at examining the possible interactions of MPEP with ionotropic 
glutamate receptors, we used pulsatile iontophoretic application of NMDA and AMPA before and during 
continuous application of MPEP (no visual stimulation was used during these experiments). Typically, 
responses were averaged over several cycles and were assessed from the accumulated count in the binned 
peristimulus time histograms. Data from individual neurons were used to compute mean values of effects. 
Statistical comparisons of these values under control conditions and during drug applications were made 
using the Wilcoxon signed rank test. Results were deemed to be significant when P < 0.05. 
Results 
The results presented in this work were obtained from neurons recorded in the A laminae of the LGN 
of adult cats whose receptive fields were within 12° of the area centralis. 
 
Effects of 2-methyl-6-(phenylethynyl)-pyridine (metabotropic glutamate receptor 5 antagonist) and (R,S)-
2-chloro-5- hydroxyphenylglycine (metabotropic glutamate receptor agonist) on visually driven activity 
 
Thirty cells (12 X, 16 Y and two unclassified) were successfully studied using a combined visual 
stimulation and pharmacological protocol. Twenty-three (77%) of these cells showed a statistically 
significant modification of their visually-evoked responses when MPEP was ejected. In these neurons 
ACh application produced a clear increment in background firing and they were therefore considered to 
be relay cells. To our surprise, the observed effect was not consistent but could be split into two distinct 
categories. 
 
(i) Cells showing a decrement in response to visual stimulation under continuous MPEP ejection (13 
of 23, 57%). This can be observed in Fig. 1 where the response of a Y ON LGN cell to a drifting 
sinusoidal grating of optimal spatial and temporal frequency (inset) before, during and after the 
ejection of MPEP is illustrated. MPEP clearly reduced (43%) the response obtained with visual 
stimulation. After a recovery period (20 min) CHPG (specific agonist of mGluR5 receptors) was 
tested on the same cell. CHPG ejection caused the opposite effect and an increment (96%) in cell 
response to visual stimulation was obtained. When CHPG was ejected simultaneously with MPEP, 
the excitatory effect of the agonist was partially blocked, showing a specific effect mediated by 
mGluR5. We also used a different type of visual stimulus, flashing spots of appropriate polarity, 
covering the receptive field. This is shown in Fig. 2. On the left, the control response obtained with 
two consecutives flashes (inset) is illustrated for an X ON neuron. After a control response was 
obtained (10 trials), in this case CHPG was first iontophoretically applied, which resulted in a clear 
increment (44%) of the visually-evoked responses. Once the cell recovered (15 min, not shown), 
MPEP was applied and, as expected, the opposite effect was obtained, with a drop in visual responses 
of 47%. After a further 25 min, the cell recovered. This type of result was found consistently in all 13 
cells [five X, seven Y, one unclassified; average decrement 59 ± 10% (SEM) with MPEP; average 
increment 68 ± 19% with CHPG], with no obvious differences between cell types. The background 
firing of these cells was similarly modulated by the applied compounds (average decrement 
64 ± 10% with MPEP; average increment 88 ± 20% with CHPG). 
(ii) Cells showing an increased response to visual stimulation in the presence of MPEP (10 of 23, 
43%). A typical example is shown in Fig. 3. We show here the response from a Y ON LGN cell to a 
drifting sinusoidal grating of optimal spatial and temporal frequency (inset) before, during and after 
the ejection of MPEP. Blocking mGluR5 significantly augmented the visual response, which 
recovered to control levels after approx. 20 min (data not shown). Figure 4 shows another example 
(X OFF) of a cell, here stimulated with drifting gratings and flashing spots. Figure 4A represents the 
visual response to several cycles of the grating. When MPEP was continuously ejected (5 min, 
middle histogram), the visual response was augmented by about 45%. Conversely, CHPG application 
induced a drop in cell firing (∼23%). Figure 4B shows the effect obtained on the same cell when the 
visual stimulus used was a flashing spot. Again, the response of the cell increased under continuous 
ejection of MPEP. CHPG application produced the opposite effect. As with the previous group, these 
results were obtained in both X and Y cells (four X and six Y; average increment 60 ± 17% with 
MPEP; average decrement 45 ± 13% with CHPG), with no obvious difference between cell types. As 
with the cells described above, the background firing of these cells was similarly modulated by the 
applied compounds (average increment 51 ± 8% with MPEP; average decrement 44 ± 16% with 
CHPG). 
 
 
 
Figure 1 The effect of 2-methyl-6-(phenylethynyl)-pyridine (MPEP) and (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) 
application on the visual responsiveness of a single ON-center Y lateral geniculate nucleus cell. The stimulus is a full field drifting 
sinusoidal grating of optimal characteristics. The inset above the records here and in subsequent figures summarizes the stimulus 
situation in concept; they do not attempt to reflect the size of the stimulus or the actual spatial frequency. Peristimulus time 
histograms illustrate the response of the cell to the grating before (Control), in the presence of the specific metabotropic glutamate 
receptor (mGluR)5 antagonist MPEP (ejected iontophoretically using 60 nA for 5 min) and after a recovery period of 20 min. The 
records shown in the bottom panel document the response of the cell to the stimulus when the mGluR5 agonist CHPG was ejected 
alone (90 nA, 10 s) and in the presence of MPEP (60 nA). Histograms were constructed from 15 presentations of the stimulus. Bin 
size, 10 ms. The receptive field of the cell obtained with sparse noise (see Materials and methods) is shown in the lower right corner 
of the figure. The spike waveform is also shown. 
Surprisingly, the two groups of cells both included both X and Y cells and we could find no 
distinguishing feature apart from their opposite responses to the applied mGluR5 (ant)agonist. In the two 
groups the effects of approximately equal potency were seen at similar ejection current levels. The level 
of spontaneous activity was similar between the two groups (39 ± 12 and 42 ± 16 spikes per bin, 
respectively) and the proportion of spikes fired in bursts (an indicator of the physiological state of the 
preparation; Rivadulla et al., 2003) in control conditions was also similar (8 vs. 10%, respectively). Cells 
in each group were found in the same animals, the same penetrations and with the same electrodes. 
 
  
 
 
 
Figure 2 The effect of 2-methyl-6-(phenylethynyl)-pyridine (MPEP) and (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) on visual 
responses obtained with flashing spots. Peristimulus time histograms (PSTHs) showing the response of a lateral geniculate nucleus 
cell (ON X) to flashed spots restricted to the receptive field center (inset above the PSTH) before (Control), during CHPG ejection 
and in the presence of MPEP. Recovery between CHPG and MPEP applications is not shown. Duration of the stimuli was 0.3 s. Bin 
size, 10 ms. CHPG ejection, 80 nA, 15 s; MPEP ejection, 80 nA, 4 min. The representation of the stimulus has a merely graphic 
purpose and does not reflect its actual properties. The receptive field of the cell is also shown above the records. 
 
 
 
Figure 3. The metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) also produced an 
increment in visually-evoked responses. Data refer to an ON Y lateral geniculate nucleus cell. 10 trials; MPEP ejection, 60 nA, 
4 min. Bin size, 10 ms, average of 10 trials. Lower right corner, receptive field of the cell. 
 
 
  
 
 
 
Figure 4. When 2-methyl-6-(phenylethynyl)-pyridine (MPEP) application increases responsiveness, (R,S)-2-chloro-5-
hydroxyphenylglycine (CHPG) produces the opposite. In this example the cell was studied with both a drifting grating and flashing 
spots as stimuli. (A) Peristimulus time histograms documenting the cell response to the grating (five cycles, 12 trials). Bin size, 
50 ms. (B) Response of the same cell to flashed spots. Bin size, 20 ms. For simplicity recoveries are not shown. MPEP ejection, 
60 nA, 5 min; CHPG ejection, 90 nA 12 s. 
2-Methyl-6-(phenylethynyl)-pyridine and N-methyl-d- aspartate/d,l-α-amino-3-hydroxy-5-α-methyl-4-
isoxazolepropionate receptor-mediated responses 
 
In order to study the effect of mGluR5 blockade and its possible interactions with glutamate 
ionotropic receptors present in the LGN, a series of pharmacological experiments without visual 
stimulation were conducted. We were able successfully to complete the experimental protocol (including 
recoveries) in 15 neurons. Responses of LGN neurons to NMDA and AMPA application were compared 
with those where MPEP was ejected simultaneously. Responses to regular iontophoretic ejection of 
agonists were recorded over several 5-min cycles before the ejection of MPEP. The antagonist was then 
continuously ejected for at least three agonist cycles and the MPEP ejection was terminated when a 
selective effect was seen or it was deemed that no effect was evident. Agonist ejection cycles were 
continued until recovery from the effects of MPEP was seen (12–17 min). We always obtained an 
excitatory response with the iontophoretic application of NMDA and AMPA. Under these conditions, in 
the majority of the cells (n = 11, 73%) MPEP did not modify AMPA (during drug response equals 
98 ± 5% of control) and NMDA (during drug response equals 105 ± 5% of control) mediated activity (see 
Fig. 5). Further, spontaneous activity was also unaffected in these cells. However, a small but significant 
number of cells (n = 4, 27%) showed responses to AMPA and NMDA which were modulated by 
concurrent application of MPEP. In these neurons, the response to both NMDA and AMPA was 
significantly reduced (by 77 ± 31% and 83 ± 12%, respectively). A representative example is shown in 
Fig. 6. All four cells were excited by the application of ACh and are therefore considered to be LGN relay 
cells. In three out of four of these cells, background activity was reduced in parallel with the effects on the 
excitatory amino acids (by 42 ± 13%) and the background activity of the remaining cell was unaffected.  
 
 
 
Figure 5. In the majority of the neurons, 2-methyl-6-(phenylethynyl)-pyridine (MPEP) applications did not change N-methyl-d-
aspartate (NMDA) (right column) and d,l-α-amino-3-hydroxy-5-α-methyl-4-isoxazolepropionate (AMPA) (left column) mediated 
responses. Peristimulus time histograms from a single cell showing the excitatory response obtained with AMPA and NMDA 
ejected iontophoretically (marker bars above the records), during continuous MPEP ejection and after a recovery period of 15 min. 
Bin size, 500 ms. 
 
 
 
Figure 6. Effect of 2-methyl-6-(phenylethynyl)-pyridine (MPEP) on N-methyl-d-aspartate (NMDA) (right column) and d,l-α-
amino-3-hydroxy-5-α-methyl-4-isoxazolepropionate (AMPA) (left column) evoked responses on another single cell (marker bars 
above the records). Note the reduction of NMDA and AMPA responses when these were coapplied with MPEP. Bin size, 500 ms.  
Discussion 
By combining electrophysiological, pharmacological and visual stimulation studies in the anesthetized 
cat, this study demonstrates, in vivo, the presence of functional mGluR5 receptors operating in the LGN. 
To a large extent our work corroborates previous findings obtained by Sherman's group which show that 
retinal synapses activate mGluRs (thought to be mGluR5) on F2 terminals (dendrites of LGN 
interneurons) promoting GABA release (Godwin et al., 1996; Cox et al., 1998). It may represent a control 
mechanism to prevent geniculate relay cells from saturating their responses under certain circumstances, 
e.g. during prolonged and intense visual stimulation (Cox et al., 1998). In this sense, our findings, where 
MPEP produced a clear increment in cell firing (and CHPG did the opposite), are clearly in favor of a role 
for mGluR5 involving this receptor in the control of GABA release. However, our data also provide a 
new and intriguing insight into the role of mGluR5 in the visual thalamus of the cat that we would like to 
discuss further. 
Modulatory effects of metabotropic glutamate receptor 5 in the lateral geniculate nucleus in vivo 
It is known that relay cells in the cat LGN receive synaptic input from a number of sources, with 
retinal input more focused toward the soma and cortical feedback located in the distal dendrites (Wilson 
et al., 1984; Erisir et al., 1997). GABAergic inhibitory inputs arise from both local inputs (both dendritic 
and axonal in nature) and from the overlying perigeniculate nucleus, the visual part of the thalamic 
reticular nucleus. These inhibitory inputs may interact locally with retinal or cortical input and 
specifically with retinal input in specialized structures called triads, where the inhibitory process receives 
direct input from the retinal synapse and, in turn, synapses on the relay cell. Such triads are most often 
found in the physiologically defined X cell type. Excitatory inputs may utilize different postsynaptic 
receptors, including both ionotropic and metabotropic (mGluR) families. By using CHPG and MPEP, 
agonist and antagonist, respectively, to mGluR5, we have found mGluR5-related activity in the two types 
of relay cells located in the A laminae of the LGN, namely X and Y. It is known that only X cells receive 
a significant number of F2 inputs (dendrites of interneurons) (Wilson et al., 1984). Therefore, in those 
neurons where the observed effect was an MPEP-induced increment of visually-evoked 
responses/background activity, the findings presented here fit with what is expected if we block mGluR5 
located within triadic arrangements (typical of X cells; Wilson et al., 1984; Hamos et al., 1985, 1987). 
However, we also achieved the same type of effect in physiologically identified Y cells. In this case, as Y 
cells do not participate in triads, we suggest that the data can be explained by the fact that mGluR5 is also 
localized on terminals belonging to perigeniculate inhibitory interneurons (although less numerous) 
whose somas lie dorsal to the LGN (Godwin et al., 1996). 
In our hands, MPEP also induced a reduction of cell firing in a significant number of cells. This effect 
cannot be explained in terms of GABA release as above. Two other, not mutually exclusive, possibilities 
may account for our findings. 
 
(i) A possible explanation derives from the fact that group I mGluRs have a dual action on 
neurotransmitter release depending on the ambient concentration of glutamate. It has been shown in 
the hippocampus that these receptors are able to accommodate glutamate release to changes in the 
surrounding concentration of glutamate, switching from facilitation to inhibition of excitatory 
synaptic transmission (Rodriguez-Moreno et al., 1998). Similar results have been found in the rat 
cortex (Alagarsamy et al., 2002). From a mechanistic point of view, in our in vivo experiments we 
have to face a very complex situation, with all regulatory systems operating and affecting the 
physiology of the cells under study with visual stimulation and ejection of drugs. These 
manipulations must produce continuous modification of glutamate release affecting the extracellular 
milieu; concomitant changes of mGluR5 action (affecting GABA release) could also be expected. 
This hypothesis, although attractive, needs experimental confirmation in the cat LGN. 
(ii) It has been shown by means of inmunohistochemistry that mGluR5 is prominently located in 
inhibitory F2 terminal profiles associated with the retinal input to LGN relay cells (Godwin et al., 
1996). Nevertheless, it was also found that a small but significant proportion of profiles (13%) 
labeled for mGluR5 but, crucially, not for GABA. These profiles are fine caliber dendrites that may 
correspond to relay cell distal dendrites in the cortical recipient zone (Godwin et al., 1996). 
Mechanistically, although this postsynaptic location of mGluR5 is not abundant, it may explain those 
effects in which MPEP reduced cell firing and CHPG increased visual responses. Despite in vitro 
studies carried out in the rat LGN (Turner & Salt, 2000), which appeared to discard a role for 
mGluR5 in corticothalamic input, the level of complexity observed in vivo and in the cat makes us 
reluctant to completely reject this as a possibility. In several preparations, including the ventrobasal 
thalamus of the rat (a nucleus devoid of interneurons), mGluR5 has been shown to potentiate 
excitatory synaptic transmission through a postsynaptic action (Salt et al., 1999; Salt & Binns, 2000) 
and has been implicated in sensory transmission. In our case, if, as suggested, the receptors are 
located on distal dendrites postsynaptically to corticofugal fibres, it is to be expected that MPEP 
application reduces cell firing. If so, it is tempting to speculate that in the cat LGN mGluR5 plays 
two different roles depending upon location. The first is related to the corticofugal feedback and is 
excitatory and the second modulates the level of inhibition and is associated with retinal input. 
Effects of 2-methyl-6-(phenylethynyl)-pyridine on ionotropic glutamate receptors 
Activation of mGluRs can modulate NMDA and AMPA receptor-mediated responses in a number of 
brain areas and cell types (for a review see Pin & Duvoisin, 1995; Bordi & Ugolini, 1999). On the other 
hand, although there is a general consensus in considering MPEP as a potent and selective antagonist of 
the mGluR5 subtype with no appreciable agonist or antagonist activity at recombinant mGluR1b, group II 
or III mGluRs or ionotropic glutamate receptors (Gasparini et al., 1999; Salt et al., 1999), some recent 
observations have raised questions about the receptor specificity of this selective antagonist and suggested 
caution in drawing conclusions about the role of mGluR5 based on the use of such compounds (O'Leary 
et al., 2000). For these reasons we felt that it was important to study the putative effect of MPEP on 
NMDA and AMPA responses. In the majority of cells our data showed that MPEP ejection produced no 
effect when applied simultaneously with the ionotropic agonists. However, it is worth noting that in 27% 
of neurons, all identified as relay cells, both NMDA and AMPA responses were clearly diminished by 
MPEP. We found no examples where the effect of NMDA/AMPA was increased by MPEP application. 
The exact mechanism by which ionotropic responses were affected is beyond the scope of our methods 
but it is important to note that the effects were seen at application current levels of MPEP no different to 
those used in the visual experiments as, although MPEP has been shown to have effects on NMDA- and 
AMPA-mediated activity not involving mGluR5 receptors (O'Leary et al., 2000), this required a dose 
level orders of magnitude larger than that producing specific mGluR5-mediated effects. It has previously 
been shown in different areas of the brain that activation of mGluR5 can potentiate NMDA (Doherty 
et al., 1997; Salt & Binns, 2000; Mannaioni et al., 2001) and AMPA (Ugolini et al., 1999) responses. 
Conclusions 
Whatever the mechanism involved, we would like to emphasize that our data strongly suggest that all 
of the visual effects obtained were mediated specifically by mGluR5 because, in all those cells studied 
using both agonist and antagonist, the effect of CHPG was the opposite to that obtained with MPEP. This 
clearly demonstrates a physiological role for mGluR5 receptors in controlling retinal input and further 
demonstrates the complexity of metabotropic receptor interactions with excitatory and inhibitory elements 
in the thalamus. The possibility of a postsynaptic locus of action (possibly via NMDA/AMPA receptors), 
associated with cortical input, could provide some functional advantage to this system, allowing a double 
control on the electrophysiological properties of the distal dendrites during situations characterized by a 
general and diffuse activation, e.g. arousal or, conversely, permitting more restrictive influence during 
sensory processing, as previously demonstrated for mGluR1 (Rivadulla et al., 2002). 
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